1 Market Overview

1.1 Product Overview and Scope of CRISPR & Cas Genes

1.2 Classification of CRISPR & Cas Genes by Type

1.2.1 Overview: Global CRISPR & Cas Genes Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global CRISPR & Cas Genes Revenue Market Share by Type in 2020

1.2.3 Vector-based Cas

1.2.4 DNA-free Cas

1.2.5 Cell Line Engineering

1.3 Global CRISPR & Cas Genes Market by Application

1.3.1 Overview: Global CRISPR & Cas Genes Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Biotechnology and Pharmaceutical Companies

1.3.3 Academics and Government Research Institutes

1.3.4 Contract Research Organizations (CROs)

1.4 Global CRISPR & Cas Genes Market Size & Forecast

1.5 Global CRISPR & Cas Genes Market Size and Forecast by Region

1.5.1 Global CRISPR & Cas Genes Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global CRISPR & Cas Genes Market Size by Region, (2016-2021)

1.5.3 North America CRISPR & Cas Genes Market Size and Prospect (2016-2026)

1.5.4 Europe CRISPR & Cas Genes Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific CRISPR & Cas Genes Market Size and Prospect (2016-2026)

1.5.6 South America CRISPR & Cas Genes Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa CRISPR & Cas Genes Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 CRISPR & Cas Genes Market Drivers

1.6.2 CRISPR & Cas Genes Market Restraints

1.6.3 CRISPR & Cas Genes Trends Analysis

2 Company Profiles

2.1 CRISPR Therapeutics

2.1.1 CRISPR Therapeutics Details

2.1.2 CRISPR Therapeutics Major Business

2.1.3 CRISPR Therapeutics CRISPR & Cas Genes Product and Solutions

2.1.4 CRISPR Therapeutics CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 CRISPR Therapeutics Recent Developments and Future Plans

2.2 AstraZeneca

2.2.1 AstraZeneca Details

2.2.2 AstraZeneca Major Business

2.2.3 AstraZeneca CRISPR & Cas Genes Product and Solutions

2.2.4 AstraZeneca CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 AstraZeneca Recent Developments and Future Plans

2.3 Addgene

2.3.1 Addgene Details

2.3.2 Addgene Major Business

2.3.3 Addgene CRISPR & Cas Genes Product and Solutions

2.3.4 Addgene CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Addgene Recent Developments and Future Plans

2.4 Caribou Biosciences, Inc.

2.4.1 Caribou Biosciences, Inc. Details

2.4.2 Caribou Biosciences, Inc. Major Business

2.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Product and Solutions

2.4.4 Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Caribou Biosciences, Inc. Recent Developments and Future Plans

2.5 Cellectis

2.5.1 Cellectis Details

2.5.2 Cellectis Major Business

2.5.3 Cellectis CRISPR & Cas Genes Product and Solutions

2.5.4 Cellectis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Cellectis Recent Developments and Future Plans

2.6 Editas Medicine, Inc.

2.6.1 Editas Medicine, Inc. Details

2.6.2 Editas Medicine, Inc. Major Business

2.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Product and Solutions

2.6.4 Editas Medicine, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Editas Medicine, Inc. Recent Developments and Future Plans

2.7 Egenesis

2.7.1 Egenesis Details

2.7.2 Egenesis Major Business

2.7.3 Egenesis CRISPR & Cas Genes Product and Solutions

2.7.4 Egenesis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Egenesis Recent Developments and Future Plans

2.8 F. Hoffmann-La Roche Ltd.

2.8.1 F. Hoffmann-La Roche Ltd. Details

2.8.2 F. Hoffmann-La Roche Ltd. Major Business

2.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product and Solutions

2.8.4 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans

2.9 Horizon Discovery Group Plc

2.9.1 Horizon Discovery Group Plc Details

2.9.2 Horizon Discovery Group Plc Major Business

2.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Product and Solutions

2.9.4 Horizon Discovery Group Plc CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Horizon Discovery Group Plc Recent Developments and Future Plans

2.10 Genscrip

2.10.1 Genscrip Details

2.10.2 Genscrip Major Business

2.10.3 Genscrip CRISPR & Cas Genes Product and Solutions

2.10.4 Genscrip CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Genscrip Recent Developments and Future Plans

2.11 Danaher Corporation

2.11.1 Danaher Corporation Details

2.11.2 Danaher Corporation Major Business

2.11.3 Danaher Corporation CRISPR & Cas Genes Product and Solutions

2.11.4 Danaher Corporation CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Danaher Corporation Recent Developments and Future Plans

2.12 Intellia Therapeutics, Inc.

2.12.1 Intellia Therapeutics, Inc. Details

2.12.2 Intellia Therapeutics, Inc. Major Business

2.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Product and Solutions

2.12.4 Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Intellia Therapeutics, Inc. Recent Developments and Future Plans

2.13 Lonza

2.13.1 Lonza Details

2.13.2 Lonza Major Business

2.13.3 Lonza CRISPR & Cas Genes Product and Solutions

2.13.4 Lonza CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Lonza Recent Developments and Future Plans

2.14 Merck KGaA

2.14.1 Merck KGaA Details

2.14.2 Merck KGaA Major Business

2.14.3 Merck KGaA CRISPR & Cas Genes Product and Solutions

2.14.4 Merck KGaA CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Merck KGaA Recent Developments and Future Plans

2.15 New England BioLabs

2.15.1 New England BioLabs Details

2.15.2 New England BioLabs Major Business

2.15.3 New England BioLabs CRISPR & Cas Genes Product and Solutions

2.15.4 New England BioLabs CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 New England BioLabs Recent Developments and Future Plans

2.16 Takara Bio, Inc.

2.16.1 Takara Bio, Inc. Details

2.16.2 Takara Bio, Inc. Major Business

2.16.3 Takara Bio, Inc. CRISPR & Cas Genes Product and Solutions

2.16.4 Takara Bio, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Takara Bio, Inc. Recent Developments and Future Plans

2.17 Synthego

2.17.1 Synthego Details

2.17.2 Synthego Major Business

2.17.3 Synthego CRISPR & Cas Genes Product and Solutions

2.17.4 Synthego CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Synthego Recent Developments and Future Plans

2.18 Mammoth Biosciences

2.18.1 Mammoth Biosciences Details

2.18.2 Mammoth Biosciences Major Business

2.18.3 Mammoth Biosciences CRISPR & Cas Genes Product and Solutions

2.18.4 Mammoth Biosciences CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Mammoth Biosciences Recent Developments and Future Plans

2.19 Inscripta, Inc.

2.19.1 Inscripta, Inc. Details

2.19.2 Inscripta, Inc. Major Business

2.19.3 Inscripta, Inc. CRISPR & Cas Genes Product and Solutions

2.19.4 Inscripta, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Inscripta, Inc. Recent Developments and Future Plans

2.20 Cibus

2.20.1 Cibus Details

2.20.2 Cibus Major Business

2.20.3 Cibus CRISPR & Cas Genes Product and Solutions

2.20.4 Cibus CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Cibus Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global CRISPR & Cas Genes Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 CRISPR & Cas Genes Players Market Share

3.2.2 Top 10 CRISPR & Cas Genes Players Market Share

3.2.3 Market Competition Trend

3.3 CRISPR & Cas Genes Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global CRISPR & Cas Genes Revenue and Market Share by Type (2016-2021)

4.2 Global CRISPR & Cas Genes Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global CRISPR & Cas Genes Revenue Market Share by Application (2016-2021)

5.2 CRISPR & Cas Genes Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America CRISPR & Cas Genes Revenue by Type (2016-2026)

6.2 North America CRISPR & Cas Genes Revenue by Application (2016-2026)

6.3 North America CRISPR & Cas Genes Market Size by Country

6.3.1 North America CRISPR & Cas Genes Revenue by Country (2016-2026)

6.3.2 United States CRISPR & Cas Genes Market Size and Forecast (2016-2026)

6.3.3 Canada CRISPR & Cas Genes Market Size and Forecast (2016-2026)

6.3.4 Mexico CRISPR & Cas Genes Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe CRISPR & Cas Genes Revenue by Type (2016-2026)

7.2 Europe CRISPR & Cas Genes Revenue by Application (2016-2026)

7.3 Europe CRISPR & Cas Genes Market Size by Country

7.3.1 Europe CRISPR & Cas Genes Revenue by Country (2016-2026)

7.3.2 Germany CRISPR & Cas Genes Market Size and Forecast (2016-2026)

7.3.3 France CRISPR & Cas Genes Market Size and Forecast (2016-2026)

7.3.4 United Kingdom CRISPR & Cas Genes Market Size and Forecast (2016-2026)

7.3.5 Russia CRISPR & Cas Genes Market Size and Forecast (2016-2026)

7.3.6 Italy CRISPR & Cas Genes Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific CRISPR & Cas Genes Revenue by Type (2016-2026)

8.2 Asia-Pacific CRISPR & Cas Genes Revenue by Application (2016-2026)

8.3 Asia-Pacific CRISPR & Cas Genes Market Size by Region

8.3.1 Asia-Pacific CRISPR & Cas Genes Revenue by Region (2016-2026)

8.3.2 China CRISPR & Cas Genes Market Size and Forecast (2016-2026)

8.3.3 Japan CRISPR & Cas Genes Market Size and Forecast (2016-2026)

8.3.4 South Korea CRISPR & Cas Genes Market Size and Forecast (2016-2026)

8.3.5 India CRISPR & Cas Genes Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia CRISPR & Cas Genes Market Size and Forecast (2016-2026)

8.3.7 Australia CRISPR & Cas Genes Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America CRISPR & Cas Genes Revenue by Type (2016-2026)

9.2 South America CRISPR & Cas Genes Revenue by Application (2016-2026)

9.3 South America CRISPR & Cas Genes Market Size by Country

9.3.1 South America CRISPR & Cas Genes Revenue by Country (2016-2026)

9.3.2 Brazil CRISPR & Cas Genes Market Size and Forecast (2016-2026)

9.3.3 Argentina CRISPR & Cas Genes Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa CRISPR & Cas Genes Revenue by Type (2016-2026)

10.2 Middle East & Africa CRISPR & Cas Genes Revenue by Application (2016-2026)

10.3 Middle East & Africa CRISPR & Cas Genes Market Size by Country

10.3.1 Middle East & Africa CRISPR & Cas Genes Revenue by Country (2016-2026)

10.3.2 Turkey CRISPR & Cas Genes Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia CRISPR & Cas Genes Market Size and Forecast (2016-2026)

10.3.4 UAE CRISPR & Cas Genes Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global CRISPR & Cas Genes Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global CRISPR & Cas Genes Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market CRISPR & Cas Genes Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global CRISPR & Cas Genes Revenue (USD Million) by Region (2016-2021)

Table 5. Global CRISPR & Cas Genes Revenue Market Share by Region (2021-2026)

Table 6. CRISPR Therapeutics Corporate Information, Head Office, and Major Competitors

Table 7. CRISPR Therapeutics Major Business

Table 8. CRISPR Therapeutics CRISPR & Cas Genes Product and Solutions

Table 9. CRISPR Therapeutics CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 11. AstraZeneca Major Business

Table 12. AstraZeneca CRISPR & Cas Genes Product and Solutions

Table 13. AstraZeneca CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Addgene Corporate Information, Head Office, and Major Competitors

Table 15. Addgene Major Business

Table 16. Addgene CRISPR & Cas Genes Product and Solutions

Table 17. Addgene CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Caribou Biosciences, Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Caribou Biosciences, Inc. Major Business

Table 20. Caribou Biosciences, Inc. CRISPR & Cas Genes Product and Solutions

Table 21. Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Cellectis Corporate Information, Head Office, and Major Competitors

Table 23. Cellectis Major Business

Table 24. Cellectis CRISPR & Cas Genes Product and Solutions

Table 25. Cellectis CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Editas Medicine, Inc. Corporate Information, Head Office, and Major Competitors

Table 27. Editas Medicine, Inc. Major Business

Table 28. Editas Medicine, Inc. CRISPR & Cas Genes Product and Solutions

Table 29. Editas Medicine, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Egenesis Corporate Information, Head Office, and Major Competitors

Table 31. Egenesis Major Business

Table 32. Egenesis CRISPR & Cas Genes Product and Solutions

Table 33. Egenesis CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors

Table 35. F. Hoffmann-La Roche Ltd. Major Business

Table 36. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product and Solutions

Table 37. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Horizon Discovery Group Plc Corporate Information, Head Office, and Major Competitors

Table 39. Horizon Discovery Group Plc Major Business

Table 40. Horizon Discovery Group Plc CRISPR & Cas Genes Product and Solutions

Table 41. Horizon Discovery Group Plc CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Genscrip Corporate Information, Head Office, and Major Competitors

Table 43. Genscrip Major Business

Table 44. Genscrip CRISPR & Cas Genes Product and Solutions

Table 45. Genscrip CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 47. Danaher Corporation Major Business

Table 48. Danaher Corporation CRISPR & Cas Genes Product and Solutions

Table 49. Danaher Corporation CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Intellia Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors

Table 51. Intellia Therapeutics, Inc. Major Business

Table 52. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product and Solutions

Table 53. Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Lonza Corporate Information, Head Office, and Major Competitors

Table 55. Lonza Major Business

Table 56. Lonza CRISPR & Cas Genes Product and Solutions

Table 57. Lonza CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 59. Merck KGaA Major Business

Table 60. Merck KGaA CRISPR & Cas Genes Product and Solutions

Table 61. Merck KGaA CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. New England BioLabs Corporate Information, Head Office, and Major Competitors

Table 63. New England BioLabs Major Business

Table 64. New England BioLabs CRISPR & Cas Genes Product and Solutions

Table 65. New England BioLabs CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Takara Bio, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. Takara Bio, Inc. Major Business

Table 68. Takara Bio, Inc. CRISPR & Cas Genes Product and Solutions

Table 69. Takara Bio, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Synthego Corporate Information, Head Office, and Major Competitors

Table 71. Synthego Major Business

Table 72. Synthego CRISPR & Cas Genes Product and Solutions

Table 73. Synthego CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Mammoth Biosciences Corporate Information, Head Office, and Major Competitors

Table 75. Mammoth Biosciences Major Business

Table 76. Mammoth Biosciences CRISPR & Cas Genes Product and Solutions

Table 77. Mammoth Biosciences CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Inscripta, Inc. Corporate Information, Head Office, and Major Competitors

Table 79. Inscripta, Inc. Major Business

Table 80. Inscripta, Inc. CRISPR & Cas Genes Product and Solutions

Table 81. Inscripta, Inc. CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Cibus Corporate Information, Head Office, and Major Competitors

Table 83. Cibus Major Business

Table 84. Cibus CRISPR & Cas Genes Product and Solutions

Table 85. Cibus CRISPR & Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global CRISPR & Cas Genes Revenue (USD Million) by Players (2019-2021)

Table 87. Global CRISPR & Cas Genes Revenue Share by Players (2019-2021)

Table 88. Breakdown of CRISPR & Cas Genes by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. CRISPR & Cas Genes Players Head Office, Products and Services Provided

Table 90. CRISPR & Cas Genes Mergers & Acquisitions in the Past Five Years

Table 91. CRISPR & Cas Genes New Entrants and Expansion Plans

Table 92. Global CRISPR & Cas Genes Revenue (USD Million) by Type (2016-2021)

Table 93. Global CRISPR & Cas Genes Revenue Share by Type (2016-2021)

Table 94. Global CRISPR & Cas Genes Revenue Forecast by Type (2021-2026)

Table 95. Global CRISPR & Cas Genes Revenue by Application (2016-2021)

Table 96. Global CRISPR & Cas Genes Revenue Forecast by Application (2021-2026)

Table 97. North America CRISPR & Cas Genes Revenue by Type (2016-2021) & (USD Million)

Table 98. North America CRISPR & Cas Genes Revenue by Type (2021-2026) & (USD Million)

Table 99. North America CRISPR & Cas Genes Revenue by Application (2016-2021) & (USD Million)

Table 100. North America CRISPR & Cas Genes Revenue by Application (2021-2026) & (USD Million)

Table 101. North America CRISPR & Cas Genes Revenue by Country (2016-2021) & (USD Million)

Table 102. North America CRISPR & Cas Genes Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe CRISPR & Cas Genes Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe CRISPR & Cas Genes Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe CRISPR & Cas Genes Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe CRISPR & Cas Genes Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe CRISPR & Cas Genes Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe CRISPR & Cas Genes Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific CRISPR & Cas Genes Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific CRISPR & Cas Genes Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific CRISPR & Cas Genes Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific CRISPR & Cas Genes Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific CRISPR & Cas Genes Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific CRISPR & Cas Genes Revenue by Region (2021-2026) & (USD Million)

Table 115. South America CRISPR & Cas Genes Revenue by Type (2016-2021) & (USD Million)

Table 116. South America CRISPR & Cas Genes Revenue by Type (2021-2026) & (USD Million)

Table 117. South America CRISPR & Cas Genes Revenue by Application (2016-2021) & (USD Million)

Table 118. South America CRISPR & Cas Genes Revenue by Application (2021-2026) & (USD Million)

Table 119. South America CRISPR & Cas Genes Revenue by Country (2016-2021) & (USD Million)

Table 120. South America CRISPR & Cas Genes Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa CRISPR & Cas Genes Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa CRISPR & Cas Genes Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa CRISPR & Cas Genes Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa CRISPR & Cas Genes Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa CRISPR & Cas Genes Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa CRISPR & Cas Genes Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. CRISPR & Cas Genes Picture

Figure 2. Global CRISPR & Cas Genes Revenue Market Share by Type in 2020

Figure 3. Vector-based Cas

Figure 4. DNA-free Cas

Figure 5. Cell Line Engineering

Figure 6. CRISPR & Cas Genes Revenue Market Share by Application in 2020

Figure 7. Biotechnology and Pharmaceutical Companies Picture

Figure 8. Academics and Government Research Institutes Picture

Figure 9. Contract Research Organizations (CROs) Picture

Figure 10. Global CRISPR & Cas Genes Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global CRISPR & Cas Genes Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global CRISPR & Cas Genes Revenue Market Share by Region (2016-2026)

Figure 13. Global CRISPR & Cas Genes Revenue Market Share by Region in 2020

Figure 14. North America CRISPR & Cas Genes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe CRISPR & Cas Genes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific CRISPR & Cas Genes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America CRISPR & Cas Genes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa CRISPR & Cas Genes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. CRISPR & Cas Genes Market Drivers

Figure 20. CRISPR & Cas Genes Market Restraints

Figure 21. CRISPR & Cas Genes Market Trends

Figure 22. CRISPR Therapeutics Recent Developments and Future Plans

Figure 23. AstraZeneca Recent Developments and Future Plans

Figure 24. Addgene Recent Developments and Future Plans

Figure 25. Caribou Biosciences, Inc. Recent Developments and Future Plans

Figure 26. Cellectis Recent Developments and Future Plans

Figure 27. Editas Medicine, Inc. Recent Developments and Future Plans

Figure 28. Egenesis Recent Developments and Future Plans

Figure 29. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans

Figure 30. Horizon Discovery Group Plc Recent Developments and Future Plans

Figure 31. Genscrip Recent Developments and Future Plans

Figure 32. Danaher Corporation Recent Developments and Future Plans

Figure 33. Intellia Therapeutics, Inc. Recent Developments and Future Plans

Figure 34. Lonza Recent Developments and Future Plans

Figure 35. Merck KGaA Recent Developments and Future Plans

Figure 36. New England BioLabs Recent Developments and Future Plans

Figure 37. Takara Bio, Inc. Recent Developments and Future Plans

Figure 38. Synthego Recent Developments and Future Plans

Figure 39. Mammoth Biosciences Recent Developments and Future Plans

Figure 40. Inscripta, Inc. Recent Developments and Future Plans

Figure 41. Cibus Recent Developments and Future Plans

Figure 42. Global CRISPR & Cas Genes Revenue Share by Players in 2020

Figure 43. CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players CRISPR & Cas Genes Revenue Market Share in 2020

Figure 45. Global Top 10 Players CRISPR & Cas Genes Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global CRISPR & Cas Genes Revenue Share by Type in 2020

Figure 48. Global CRISPR & Cas Genes Market Share Forecast by Type (2021-2026)

Figure 49. Global CRISPR & Cas Genes Revenue Share by Application in 2020

Figure 50. Global CRISPR & Cas Genes Market Share Forecast by Application (2021-2026)

Figure 51. North America CRISPR & Cas Genes Sales Market Share by Type (2016-2026)

Figure 52. North America CRISPR & Cas Genes Sales Market Share by Application (2016-2026)

Figure 53. North America CRISPR & Cas Genes Revenue Market Share by Country (2016-2026)

Figure 54. United States CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe CRISPR & Cas Genes Sales Market Share by Type (2016-2026)

Figure 58. Europe CRISPR & Cas Genes Sales Market Share by Application (2016-2026)

Figure 59. Europe CRISPR & Cas Genes Revenue Market Share by Country (2016-2026)

Figure 60. Germany CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific CRISPR & Cas Genes Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific CRISPR & Cas Genes Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific CRISPR & Cas Genes Revenue Market Share by Region (2016-2026)

Figure 68. China CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America CRISPR & Cas Genes Sales Market Share by Type (2016-2026)

Figure 75. South America CRISPR & Cas Genes Sales Market Share by Application (2016-2026)

Figure 76. South America CRISPR & Cas Genes Revenue Market Share by Country (2016-2026)

Figure 77. Brazil CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa CRISPR & Cas Genes Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa CRISPR & Cas Genes Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa CRISPR & Cas Genes Revenue Market Share by Country (2016-2026)

Figure 82. Turkey CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE CRISPR & Cas Genes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source